Efficacy of natalizumab in second line therapy of relapsing–remitting multiple sclerosis: results from a multi-center study in German speaking countries
N. Putzki, O. Yaldizli, M. Mäurer, S. Cursiefen, S. Kuckert, C. Klawe, M. Maschke, B. Tettenborn, V. LimmrothVolume:
17
Year:
2010
Language:
english
Pages:
7
DOI:
10.1111/j.1468-1331.2009.02728.x
File:
PDF, 155 KB
english, 2010